2562 Stock Overview
Brother Enterprises Holding Co.,Ltd. engages in the research and development, production, and sale of leather chemicals in China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Brother Enterprises Holding Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.37 |
52 Week High | CN¥4.80 |
52 Week Low | CN¥2.51 |
Beta | 0.36 |
1 Month Change | -5.07% |
3 Month Change | 8.71% |
1 Year Change | -31.36% |
3 Year Change | -27.53% |
5 Year Change | -27.53% |
Change since IPO | -25.11% |
Recent News & Updates
Shareholder Returns
2562 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 6.3% | 4.8% | 4.2% |
1Y | -31.4% | -18.0% | -13.2% |
Return vs Industry: 002562 underperformed the CN Chemicals industry which returned -18% over the past year.
Return vs Market: 002562 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
2562 volatility | |
---|---|
2562 Average Weekly Movement | 9.1% |
Chemicals Industry Average Movement | 8.7% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002562 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002562's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 3,052 | Jianping Li | www.brother.com.cn |
Brother Enterprises Holding Co.,Ltd. engages in the research and development, production, and sale of leather chemicals in China and internationally. It operates in six segments: Vitamins, Spices, Active Pharmaceutical Ingredients, Leather Chemicals, Chrome Salt, and Catalyst.
Brother Enterprises Holding Co.,Ltd. Fundamentals Summary
2562 fundamental statistics | |
---|---|
Market cap | CN¥3.58b |
Earnings (TTM) | -CN¥211.39m |
Revenue (TTM) | CN¥2.97b |
1.2x
P/S Ratio-17.0x
P/E RatioIs 2562 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2562 income statement (TTM) | |
---|---|
Revenue | CN¥2.97b |
Cost of Revenue | CN¥2.71b |
Gross Profit | CN¥255.13m |
Other Expenses | CN¥466.52m |
Earnings | -CN¥211.39m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.20 |
Gross Margin | 8.60% |
Net Profit Margin | -7.13% |
Debt/Equity Ratio | 58.1% |
How did 2562 perform over the long term?
See historical performance and comparison